Goldman Sachs’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-156,300
Closed -$1.14M 6629
2025
Q4
$1.14M Hold
156,300
﹤0.01% 5043
2025
Q3
$1.56M Buy
+156,300
New +$1.73M ﹤0.01% 4693
2025
Q1
Sell
-1,694,743
Closed -$16.1M 6147
2024
Q4
$16.1M Sell
1,694,743
-268,800
-14% -$2.36M ﹤0.01% 2342
2024
Q3
$16M Buy
1,963,543
+749,943
+62% +$7.79M ﹤0.01% 2258
2024
Q2
$16.4M Buy
1,213,600
+109,714
+10% +$917K ﹤0.01% 2041
2024
Q1
$7.74M Sell
1,103,886
-6,057
-0.5% -$52.6K ﹤0.01% 2714
2023
Q4
$12.2M Buy
1,109,943
+286,286
+35% +$2.81M ﹤0.01% 2350
2023
Q3
$9.04M Sell
823,657
-2,320,800
-74% -$33.2M ﹤0.01% 2477
2023
Q2
$49.6M Buy
3,144,457
+3,087,314
+5,403% +$35.9M 0.01% 1105
2023
Q1
$746K Buy
+57,143
New +$469K ﹤0.01% 4597

Other funds holding ENVX

Goldman Sachs's ENVX Position: Q1 2026 in Review

Goldman Sachs reduced its Enovix (ENVX) stake by 12% in Q1 2026, selling an estimated $1.13M and leaving 1,361,957 shares worth $7.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3363.

Goldman Sachs first reported a position in ENVX in Q1 2021 and has held it in 21 quarters since. The position peaked at $54.6M in Q2 2023. 306 funds tracked by Wall St. Rank hold ENVX as of Q1 2026.

  • Goldman Sachs held 1,361,957 shares of Enovix worth $7.05M as of Q1 2026.
  • Goldman Sachs sold 181,293 Enovix shares in Q1 2026, an estimated $1.13M.
  • Enovix made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3363 holding.
  • Goldman Sachs first reported a position in Enovix in Q1 2021 and has held it in 21 quarters since.
  • Goldman Sachs's Enovix position peaked at $54.6M in Q2 2023.
  • 306 funds tracked by Wall St. Rank held Enovix as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.